Rehabiliation Using HUBER 360 to Reduce the Risk of Falls

Study Overview
=================
Brief Summary
-----------------
Aim: The aim of the present study was to analyse the effects of training performed on a rotating, motorised platform (the Huber/SpineForce device from LPG Systems, Valence, France) intended to reduce the risk of falls. Subjects: any patient 1) benefiting from a physiotherapy rehabilitation program at the CHU Liège, CNRF, Belgium; 2) presenting a pathological situation justifying functional rehabilitation with HUBER 360®; 3) presenting any pathology not constituting an exclusion criterion; 4) giving informed consent to research will be include in this 8-week interventional trial. Design: randomized open-label trial. Patients will be randomized into the intervention group (HUBER trainig, 45 minutes of training, twice a week during 8 weeks) or in the control group (standard care). Outcomes: the effect of the training will be measured on the Time-Up-and-Go test, on the Short-Physical performance battery test and on quality of life.

Official Title
-----------------
Investigation of the Effectiveness of Rehabilitation Using the HUBER 360 Tool to Reduce the Risk of Falls in People in Pathological Situations Requiring Functional Rehabilitation

Conditions
-----------------
Fall, Rehabilitation, Exercise Therapy, Treatment Outcome, Quality of Life

Intervention / Treatment
-----------------
* Device: HUBER (LPG Systems, France)


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient benefiting from a physiotherapy rehabilitation program at the CHU Liège, CNRF Patient presenting a pathological situation justifying functional rehabilitation with HUBER 360® Patient presenting any pathology not constituting an exclusion criterion Patient giving informed consent to research. Exclusion Criteria: Cardiac or respiratory or neurological or rheumatological disease incompatible with physical activity ; Joint inflammation; Rheumatic disease in acute phase; Recent trauma, infection of the musculoskeletal system; Fever; Venous thrombosis ; Discopathy in acute phase; Neuropsychological problems that do not allow to integrate the instructions or other serious psychological problems; Cardiovascular diseases and any progressive, chronic, counter-indicative disease; Large anatomical deformities.
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: HUBER<br>HUBER is an isometric strengthening device. It consists of an oval motorized platform, which performs rotating, oscillatory movements with a controlled amplitude and speed. Intervention will consist of 2 sessions of HUBER per week. Each session lasts approximatively 30 minutes. The intervention is 8 weeks long. | Device: HUBER (LPG Systems, France)<br>* The HUBER® device consists of an oval motorized platform, which performs rotating, oscillatory movements with a controlled amplitude and speed. It also comprises, two large handles with force sensors, mounted on a movable column. Its originality is based on its capacity to capture simultaneously the subjects' balance, core stability, core strength and total body strength; and adapt the training accordingly. Indeed, the platform interferes with the balance of the patient who must continually adjust his/her posture by exerting isometric pushing and pulling efforts with the arms. As a result, the device provides postural and muscle adaptation with visual feedback. Due to the constant adaptation of the device, it is thought to enhance muscular strength and improve neuromuscular coordination simultaneously.<br>|
| No Intervention: Control<br>The control group will not received any intervention except usual care. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Risk of falls, in seconds | Measured with Timed-Up-and Go test | 8 weeks | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Physical performance | Short Physical Performance Battery test (SPPB test). The test is scored from 0 (lower physical performance) to 12 (highest physical performance) | 8 weeks | 
| Quality of life, measured with the Short Form-36 questionnaire | SF-36 generic quality of life questionnaire. The score obtained from this questionnaire is composed with a Physcial component Scale (PMS) and a Mental component scale (MCS). Results are scored from 0 (worst quality of life) to 100 (best quality of life). | 8 weeks | 
| Utility score using the EuroQol- 5 Dimension questionnaire | Descriptive data from the 5 dimensions can be used to generate a health-related quality of life profile for the subject. The questionnaire is scored from 0 (worst health state imaginable) to 100 (best health state imaginable). | 8 weeks | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Huber